The Personalized Medicine Coalition (PMC), representing innovators, scientists, patients, providers and payers, promotes the understanding and adoption of personalized medicine concepts, services and products to benefit patients and the health system. An educational and advocacy organization with more than 240 institutional members, PMC promotes personalized medicine by addressing regulatory, reimbursement and clinical adoption issues critical to the field.
For more information about PMC, visit www.personalizedmedicinecoalition.org
Follow PMC on Twitter: @permedcoalition
Follow PMC’s Education & Advocacy blog: https://personalizedmedicinecoalition.wordpress.com
Founded in 1907, the American Association for Cancer Research (AACR) is the world’s oldest and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR membership includes more than 35,000 laboratory, translational, and clinical researchers; population scientists; other health care professionals; and patient advocates residing in 101 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, biology, diagnosis, and treatment of cancer by annually convening more than 30 conferences and educational workshops, the largest of which is the AACR Annual Meeting with over 19,300 attendees. In addition, the AACR publishes eight prestigious, peer-reviewed scientific journals and a magazine for cancer survivors, patients, and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the Scientific Partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration, and scientific oversight of team science and individual investigator grants in cancer research that have the potential for near-term patient benefit. The AACR actively communicates with legislators and other policymakers about the value of cancer research and related biomedical science in saving lives from cancer.
For more information about the AACR, visit www.AACR.org
Feinstein Kean Healthcare (FKH) is a leading strategy and communications consultancy serving emerging and established organizations whose innovations are helping to transform life sciences and healthcare. The firm works with clients at the intersection where disruptive technologies and ideas influence medicine, clinical research and practice, business models, public policy, and public opinion and behaviors. For more than 25 years, FKH has been a trusted partner to leading pharmaceutical, healthcare, technology, biotechnology, informatics and patient advocacy organizations. Hundreds of clients have turned to FKH to develop and execute programs that drive product commercialization; forge partnerships; transform markets; build constituencies and help to shape policies. FKH established the first personalized medicine practice in the nation in 2004, and has worked with industry, academe and government to advance adoption of personalized medicine approaches ever since.
For more information about FKH, visit www.fkhealth.com